Distribution of Beta-1 Transforming Growth Factor Gene Polymorphism (T869C) in Psoriasis Patients in Medan, North Sumatra
Abstract
Keywords
Full Text:
PDFReferences
Dsouza Priya Hilda, Maria Kuruville. Dyslipidemia in psoriasis: as a riskfor cardiovascular disease. Int J Res Med Sci. 2013; 1(2):53-7.
Boehncke, W.H. Etiology and Pathogenesis of Psoriasis. Rheum Dis Clin N Am. 2015; 41:665-75.
World Health Organization (WHO). Global report on Psoriasis, Switzerland: 2016.
Zeng J, Luo S, Huang Y, Lu Q. Critical role of environmental factors in the pathogenesis of psoriasis. J Dermatol. 2017; 44:863-72.
Tang H, Jin X, Li Y, Jiang H, Tang X, Yang X et al. A large-scale screen for coding variants predisposing to psoriasis. Nat Genet. 2014; 46:4550.
Baurecht H, Hotze M, Brand S, Buning C, Cormican P, Corvin A et al. Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. Am J Hum Genet. 2015; 96:104-20.
Guttman-Yassky E, Krueger JG, Lebwohl MG. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Exp Dermatol. 2017: 13336.
Rusmawardiana, j. b. s. J. F. R. H. Analisis polimorfisme Alpha-Helix Coiled Coil Rod Homologue Gene Exon 2 pada penderita psoriasis ras melayu di Palembang. JBP. 2012; 14(2),pp: 79-85.
Waworuntu, G, Chairiyah T, Irma D. Roesyanto-Mahadi. Profil kadar Vascular Endothelial Growth Factor (VEGF) Serum Berdasarkan Karakteristik Pasien Psoriasis Vulgaris Di RSUP H. Adam Malik Medan. MDVI. 2017; Volume 44:8-14.
Gudjonsson, J.E, Elder, J.T. Psoriasis. In Fitzpatricks Dermatology in General Medicine. 2012. 8th ed; Goldsmith, L.A., Katz, S.I., Eds.; McGrawHill: New York, NJ, USA; pp:169-93.
Xu, X, Zhang, H. Y. The immunogenetics of Psoriasis and Implication for Drug Repositoning. International Journal of molecular Sciences. 2017;18(12).
Han, G et al. A Role for TGFbeta Signaling in the Pathogenesis of Psoriasis. J Invest Dermatol. 2010; 130(2):371-77.
Mekl, A. R, Al-Shoballl, H. Serum Vascular Endothelial Growth Factor, Transforming Growth Factor ?1, and Nitric Oxide Levels in Patients with Psoriasis Vulgaris: Their Correlation to Disease Severity. J Clin Lab Anal. 2014; 28(6):496-501.
Kitoh, A.; Nomura, T.; Kabashima, K. TGF_1, an epidermal controller of skin dendritic cell homeostasis. J. Investig. Dermatol. 2013; 133:9-11.
Zhang, Y.; Meng, X.M.; Huang, X.R.; Wang, X.J.; Yang, L.; Lan, H.Y. Transforming growth factor-_1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice. Clin. Exp. Pharmacol. Physiol. 2014; 41:92-932.
Zhou T, Hong-Yan L, Hongzhen Z, dan Zhiqing Z. Relationship Between Transforming Growth Factor-?1 and Type 2 diabetic Nephropathy Risk in Chinese Populayion. BMC Medical Genetics. 2018.
El-Hadidi, H.H., A.S. Hassan, G. El-hanafi, K.S. Amr, S.F. Abdelmesih, M.F. Abdelhamid. Transforming Growth Factor-?1 Gene Polymorphism in Psoriasis Vulgaris. Clinical, Cosmetic and investigational Dermatoloy. 2018; 11:415-19.
Baran, W., J.C. Szepietowski., G. Mazur, dan E. Baran. TGF-?1 Gene Polymorphism in Psoriasis Vulgaris. Cytokine. 2007; 38(1):8-11.
Lyko F, Paro R, Chromosomal elements conferring epigenetic inheritance. Bioessays 1999; 21:824-32.
Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014; 13(4-5):490-5.
DOI: https://doi.org/10.30596/bf.v6i1.3981
DOI (PDF): https://doi.org/10.30596/bf.v6i1.3981.g5258
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.